- Home
- DGX vs CAVA Comparison
DGX vs CAVA Comparison
Compare DGX & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGX
- CAVA
- Stock Information
- Founded
- DGX 1967
- CAVA 2006
- Country
- DGX United States
- CAVA United States
- Employees
- DGX N/A
- CAVA N/A
- Industry
- DGX Medical Specialities
- CAVA Restaurants
- Sector
- DGX Health Care
- CAVA Consumer Discretionary
- Exchange
- DGX Nasdaq
- CAVA Nasdaq
- Market Cap
- DGX 17.5B
- CAVA 16.2B
- IPO Year
- DGX 1996
- CAVA 2023
- Fundamental
- Price
- DGX $151.26
- CAVA $117.27
- Analyst Decision
- DGX Buy
- CAVA Buy
- Analyst Count
- DGX 14
- CAVA 13
- Target Price
- DGX $168.14
- CAVA $144.77
- AVG Volume (30 Days)
- DGX 794.0K
- CAVA 2.8M
- Earning Date
- DGX 01-30-2025
- CAVA 11-12-2024
- Dividend Yield
- DGX 1.97%
- CAVA N/A
- EPS Growth
- DGX 11.56
- CAVA N/A
- EPS
- DGX 7.44
- CAVA 0.46
- Revenue
- DGX $9,539,000,000.00
- CAVA $913,488,000.00
- Revenue This Year
- DGX $7.33
- CAVA $34.56
- Revenue Next Year
- DGX $8.70
- CAVA $23.50
- P/E Ratio
- DGX $20.46
- CAVA $253.88
- Revenue Growth
- DGX 2.60
- CAVA 34.05
- 52 Week Low
- DGX $123.04
- CAVA $39.05
- 52 Week High
- DGX $165.32
- CAVA $172.43
- Technical
- Relative Strength Index (RSI)
- DGX 35.27
- CAVA 30.37
- Support Level
- DGX $152.18
- CAVA $123.15
- Resistance Level
- DGX $156.54
- CAVA $127.05
- Average True Range (ATR)
- DGX 2.85
- CAVA 6.11
- MACD
- DGX -1.09
- CAVA -2.70
- Stochastic Oscillator
- DGX 0.00
- CAVA 3.12
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates the majority of its revenue from the CAVA segment.